- Home
- LAMR vs ICLR Comparison
LAMR vs ICLR Comparison
Compare LAMR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAMR
- ICLR
- Stock Information
- Founded
- LAMR 1902
- ICLR 1990
- Country
- LAMR United States
- ICLR Ireland
- Employees
- LAMR N/A
- ICLR N/A
- Industry
- LAMR Real Estate Investment Trusts
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LAMR Real Estate
- ICLR Health Care
- Exchange
- LAMR Nasdaq
- ICLR Nasdaq
- Market Cap
- LAMR 12.1B
- ICLR 11.4B
- IPO Year
- LAMR 1996
- ICLR 1998
- Fundamental
- Price
- LAMR $120.09
- ICLR $146.48
- Analyst Decision
- LAMR Buy
- ICLR Buy
- Analyst Count
- LAMR 6
- ICLR 12
- Target Price
- LAMR $131.83
- ICLR $204.18
- AVG Volume (30 Days)
- LAMR 436.4K
- ICLR 1.1M
- Earning Date
- LAMR 08-07-2025
- ICLR 07-23-2025
- Dividend Yield
- LAMR 5.15%
- ICLR N/A
- EPS Growth
- LAMR N/A
- ICLR 11.53
- EPS
- LAMR 4.11
- ICLR 9.19
- Revenue
- LAMR $2,220,416,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- LAMR $4.78
- ICLR N/A
- Revenue Next Year
- LAMR $3.54
- ICLR $2.10
- P/E Ratio
- LAMR $29.07
- ICLR $15.62
- Revenue Growth
- LAMR 3.72
- ICLR N/A
- 52 Week Low
- LAMR $99.84
- ICLR $125.10
- 52 Week High
- LAMR $139.88
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- LAMR 54.63
- ICLR 58.35
- Support Level
- LAMR $117.89
- ICLR $140.20
- Resistance Level
- LAMR $122.67
- ICLR $147.26
- Average True Range (ATR)
- LAMR 1.89
- ICLR 5.06
- MACD
- LAMR -0.31
- ICLR 1.39
- Stochastic Oscillator
- LAMR 46.03
- ICLR 85.25
About LAMR Lamar Advertising Company
Lamar Advertising Co is an outdoor advertising companies in the United States and operates as a Real Estate Investment Trust. It rent space for advertising on billboards, buses, shelters, benches, logo plates and in airport terminals and also offer customers a fully integrated service with all aspects of their display requirements from ad copy production to placement and maintenance. It has two operating segments: billboard and Others. Key revenue is generated from Billboard segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.